Jason Jalil

1.4k total citations · 1 hit paper
13 papers, 930 citations indexed

About

Jason Jalil is a scholar working on Oncology, Immunology and Psychiatry and Mental health. According to data from OpenAlex, Jason Jalil has authored 13 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Immunology and 3 papers in Psychiatry and Mental health. Recurrent topics in Jason Jalil's work include Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and CAR-T cell therapy research (4 papers). Jason Jalil is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and CAR-T cell therapy research (4 papers). Jason Jalil collaborates with scholars based in United States, Canada and Poland. Jason Jalil's co-authors include Antoni Ribas, Richard C. Koya, Begoña Comı́n-Anduix, Jesús Gómez-Navarro, Thinle Chodon, Bartosz Chmielowski, John A. Glaspy, James S. Economou, Alistair J. Cochran and Gary W. Small and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Jason Jalil

13 papers receiving 906 citations

Hit Papers

Brain health consequences of digital technology use 2020 2026 2022 2024 2020 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Brain health consequences of digital technology use
    2020 161 citations Gary W. Small, Jooyeon Lee et al. Dialogues in Clinical Neuroscience profile →

Peers

Jason Jalil
Rebecca Robbins United States
Agustín Lage Cuba
Laurie Ford United States
Ivan Dimitrijević Serbia
Yonghong Zhang United States
Hsing-Ying Ho Taiwan
Maria Agthe Germany
Sarah J. Shin United States
Kelly Hall United States
Rebecca Robbins United States
Jason Jalil
Citations per year, relative to Jason Jalil Jason Jalil (= 1×) peers Rebecca Robbins

Countries citing papers authored by Jason Jalil

Since Specialization
Citations

This map shows the geographic impact of Jason Jalil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Jalil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Jalil more than expected).

Fields of papers citing papers by Jason Jalil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Jalil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Jalil. The network helps show where Jason Jalil may publish in the future.

Co-authorship network of co-authors of Jason Jalil

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Jalil. A scholar is included among the top collaborators of Jason Jalil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Jalil. Jason Jalil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Oughli, Hanadi Ajam, Helen Lavretsky, Jason Jalil, et al.. (2022). Optimizing Outcomes of Treatment-Resistant Depression (TRD) in Older Adults (OPTIMUM): Measures of Psychological Well-Being. American Journal of Geriatric Psychiatry. 30(4). S111–S112. 1 indexed citations
2.
Jalil, Jason, et al.. (2022). Polypharmacy in Treatment of Behavioral Issues in Dementia—Use of Atypical Antipsychotics. Clinics in Geriatric Medicine. 38(4). 641–652. 4 indexed citations
3.
Small, Gary W., Jooyeon Lee, Aaron Kaufman, et al.. (2020). Brain health consequences of digital technology use. Dialogues in Clinical Neuroscience. 22(2). 179–187. 161 indexed citations breakdown →
4.
Chen, Stephen T., et al.. (2018). Health-Promoting Strategies for the Aging Brain. American Journal of Geriatric Psychiatry. 27(3). 213–236. 17 indexed citations
5.
Ibarrondo, F. Javier, Otto O. Yang, Thinle Chodon, et al.. (2013). Natural Killer T Cells in Advanced Melanoma Patients Treated with Tremelimumab. PLoS ONE. 8(10). e76829–e76829. 14 indexed citations
6.
Huang, Rong, Jason Jalil, James S. Economou, et al.. (2011). CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans. Clinical Cancer Research. 17(12). 4101–4109. 120 indexed citations
7.
Comı́n-Anduix, Begoña, Hooman Sazegar, Thinle Chodon, et al.. (2010). Modulation of Cell Signaling Networks after CTLA4 Blockade in Patients with Metastatic Melanoma. PLoS ONE. 5(9). e12711–e12711. 23 indexed citations
8.
Comı́n-Anduix, Begoña, Thinle Chodon, Hooman Sazegar, et al.. (2010). The Oncogenic BRAF Kinase Inhibitor PLX4032/RG7204 Does Not Affect the Viability or Function of Human Lymphocytes across a Wide Range of Concentrations. Clinical Cancer Research. 16(24). 6040–6048. 111 indexed citations
9.
Ribas, Antoni, Begoña Comı́n-Anduix, Bartosz Chmielowski, et al.. (2009). Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma. Clinical Cancer Research. 15(19). 6267–6276. 163 indexed citations
10.
Euw, Erika von, Thinle Chodon, Narsis Attar, et al.. (2009). CTLA4 blockade increases Th17 cells in patients with metastatic melanoma. Journal of Translational Medicine. 7(1). 35–35. 135 indexed citations
11.
Ribas, Antoni, Begoña Comı́n-Anduix, James S. Economou, et al.. (2008). Intratumoral Immune Cell Infiltrates, FoxP3, and Indoleamine 2,3-Dioxygenase in Patients with Melanoma Undergoing CTLA4 Blockade. Clinical Cancer Research. 15(1). 390–399. 111 indexed citations
12.
Comı́n-Anduix, Begoña, Jason Jalil, Alain P. Algazi, et al.. (2008). Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma. Journal of Translational Medicine. 6(1). 22–22. 64 indexed citations
13.
Ribas, Antoni, Viviana Bozón, Luis H. Camacho, et al.. (2006). Antigen-specific T cell responses in patients with melanoma treated with the CTLA4 blocking mAb ticilimumab. Journal of Clinical Oncology. 24(18_suppl). 8033–8033. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rebecca Robbins Breakdown of academic impact, for papers by Agustín Lage Breakdown of academic impact, for papers by Laurie Ford Breakdown of academic impact, for papers by Ivan Dimitrijević Breakdown of academic impact, for papers by Yonghong Zhang Breakdown of academic impact, for papers by Hsing-Ying Ho Breakdown of academic impact, for papers by Maria Agthe Breakdown of academic impact, for papers by Sarah J. Shin Breakdown of academic impact, for papers by Kelly Hall
Rankless by CCL
2026